# Atacand (Candesartan) Real Life Study

> **NCT00620178** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 14000 (estimated)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Candesartan Cilexetil
- **DRUG:** Losartan

## Key facts

- **NCT ID:** NCT00620178
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2009-02
- **Final completion:** 2009-02
- **Target enrollment:** 14000 (ESTIMATED)
- **Last updated:** 2010-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00620178

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00620178, "Atacand (Candesartan) Real Life Study". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00620178. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*